Sandford D. Smith - Jul 19, 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
By: Robert Wong For: Sandford Smith
Stock symbol
CYTK
Transactions as of
Jul 19, 2021
Transactions value $
-$217,681
Form type
4
Date filed
7/21/2021, 05:14 PM
Previous filing
Jul 8, 2021
Next filing
Oct 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $53.4K +5K +77.41% $10.68 11.5K Jul 19, 2021 Direct F1, F2
transaction CYTK Common Stock Sale -$145K -5K -43.63% $29.00 6.46K Jul 19, 2021 Direct F1, F2
transaction CYTK Common Stock Options Exercise $21K +1.97K +30.42% $10.68 8.42K Jul 19, 2021 Direct F1, F2
transaction CYTK Common Stock Sale -$58K -1.97K -23.33% $29.50 6.46K Jul 19, 2021 Direct F1, F2
transaction CYTK Common Stock Options Exercise $53.4K +5K +77.41% $10.68 11.5K Jul 19, 2021 Direct F1, F2
transaction CYTK Common Stock Sale -$143K -5K -43.63% $28.50 6.46K Jul 19, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -33.33% $0.00 10K Jul 19, 2021 Common Stock 5K $10.68 Direct F1
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.97K -19.65% $0.00 8.04K Jul 19, 2021 Common Stock 1.97K $10.68 Direct F1
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -62.23% $0.00 3.04K Jul 19, 2021 Common Stock 5K $10.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021.
F2 Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.